News

The Dubs might not have the same strength in their numbers that they once boasted. Curry and Draymond Green’s legs might not ...
What do sickle cell anaemia, Kashmir’s pashmina goats, and Kerala's karimeen have in common with the resurrected wolf? A ...
Endpoints Weekly covers Q1 earnings from major pharma companies, with focus on tariff concerns. FDA's Makary discusses new rare disease pathway, and HuidaGene reports first brain CRISPR treatment.
Trump's second term is playing out a lot differently than health care companies and their lobbyists hoped for.